Table 1 Pathway map enrichment analysis
# | Maps | Maps folder | p value |
|---|---|---|---|
1 | Granzyme A signaling | Apoptosis and survival | 6.81E-08 |
2 | TGF, WNT and cytoskeletal remodeling | Cytoskeleton remodeling | 2.68E-07 |
3 | Antigen presentation by MHC class I | Immune response | 3.65E-07 |
4 | IGF-1 receptor signaling | Development | 4.78E-06 |
5 | Androgen Receptor nuclear signaling | Transcription | 6.57E-06 |
6 | Glucocorticoid receptor signaling | Development | 1.01E-05 |
7 | ATM/ATR regulation of G1/S checkpoint | DNA damage | 1.34E-05 |
8 | LRRK2 in neurons in Parkinson's disease | 1.77E-05 | |
9 | GM-CSF signaling | Development | 1.94E-05 |
10 | Endothelial cell contacts by junctional mechanisms | Cell adhesion | 1.98E-05 |
11 | Cytoskeleton remodeling | Cytoskeleton remodeling | 2.64E-05 |
12 | AKT signaling | Signal transduction | 2.78E-05 |
13 | Endoplasmic reticulum stress response pathway | Apoptosis and survival | 3.48E-05 |
14 | Role of Activin A in cell differentiation and proliferation | Development | 9.27E-05 |
15 | WNT signaling pathway. Part 2 | Development | 1.84E-04 |
16 | WNT signaling pathway. Part 1. Degradation of beta-catenin in the absence WNT signaling | Development | 1.92E-04 |
17 | TGF-beta-dependent induction of EMT via SMADs | Development | 2.03E-04 |
18 | Mismatch repair | DNA damage | 2.63E-04 |